Content by IsoPlexis

How single-cell secretomic analysis revealed the role of TEMRA CD8⁺ T cells in kidney transplant rejection.

In this webinar, Abhishek Garg will discuss using functional proteomics and multi-omics approaches to explore exhausted/dysfunctional T cell states in various cancers.

An expert panel will discuss how a functional cell library confirms critical insights from previous omics studies. Additionally, they will introduce an innovative platform that connects single cell transcriptomics with functional proteomics for the first time.

Rui Zheng and Patrick Paczkowski will discuss a new, highly multiplexed, simultaneous single cell transcriptomics and functional proteomics platform.

Explore how scientists characterize immune cell functional behavior in response to cancer, and how they harness this information for therapeutic purposes.

David Miklos discusses recent advances in bispecific CAR-T therapy development.

Jessica Morris will discuss strategies to improve CAR-T cell targeting, activation, and killing capabilities.

Researchers use a mesenchymal stromal cell-based vector to deliver multiple viruses simultaneously to improve CAR-T cell anti-tumor activity.

New cytokine analysis technology advances cancer therapeutics and vaccine development.

Functional profiling of immune cells uncovers targetable mechanisms underlying lung inflammation in severe COVID disease.

An improved ELISA-based proteomics chip detects cytokines in single cell applications.

Katie McKenna discusses a combination CAR T and viral therapy that kills solid tumors.

Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.

A tumor metabolome panel identifies altered cell states that lead to drug tolerance.